Publication | Closed Access

Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation

Medicinal ChemistryMedicineVegfr-2 Kinase InhibitorsRational Drug DesignAnti-cancer AgentDrug DevelopmentRadiation OncologyPharmacologyMolecular ModelingPharmaceutical ChemistryTumor MicroenvironmentPotential Anticancer EvaluationDrug Discovery